Finance

Lists
1786:TPE
SciVision Biotech Inc
NT$49.95
-1.28%
(-0.65) 1D
Nov 16, 1:30:34 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1786...
Open
NT$50.50
High
NT$53.30
Low
NT$49.95
Mkt. cap
3.74B
Avg. vol.
730.08K
Volume
812.20K
Dividend
3.82%
Quarterly dividend
NT$0.48
Ex-dividend date
Jul 24, 2024
P/E ratio
27.34
52-wk high
NT$87.50
52-wk low
NT$38.80
EPS
NT$1.83
Shares outstanding
53.10M
No. of employees
64
Open
NT$50.50
High
NT$53.30
Low
NT$49.95
Mkt. cap
3.74B
Avg. vol.
730.08K
Volume
812.20K
Dividend
3.82%
Quarterly dividend
NT$0.48
Ex-dividend date
Jul 24, 2024
P/E ratio
27.34
52-wk high
NT$87.50
52-wk low
NT$38.80
EPS
NT$1.83
Shares outstanding
53.10M
No. of employees
64
News stories
From web sources and news partners
About SciVision Biotech Inc
CEO-
Employees64
Founded1990
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
251.39M
205.32M
211.03M
202.67M
Cost of goods sold
62.04M
60.12M
71.98M
61.50M
Cost of revenue
62.04M
60.12M
71.98M
61.50M
Research and development expenses
32.38M
22.94M
20.75M
22.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107.04M
100.96M
89.57M
85.47M
Operating expense
139.42M
123.90M
110.32M
108.30M
Total operating expenses
201.46M
184.02M
182.30M
169.80M
Operating income
49.93M
21.30M
28.73M
32.87M
Other non operating income
2.19M
1.30M
51.00K
-9.91M
EBT including unusual items
72.40M
35.68M
27.57M
24.25M
EBT excluding unusual items
74.54M
35.70M
28.60M
24.25M
Income tax expense
9.21M
13.73M
-7.08M
1.22M
Effective tax rate
12.72%
38.47%
-25.67%
5.02%
Other operating expenses
-
-
-
-
Net income
63.18M
21.96M
34.64M
23.03M
Net profit margin
25.13%
10.69%
16.42%
11.37%
Earnings per share
-
-
-
-
Interest and investment income
8.75M
6.50M
7.42M
4.43M
Interest expense
-3.18M
-3.12M
-3.10M
-3.14M
Net interest expenses
5.57M
3.37M
4.32M
1.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
68.84M
41.06M
49.04M
61.78M
Gain or loss from assets sale
10.00K
16.00K
-23.00K
-
Upcoming events
AI content may include mistakes. Learn more
Google apps